0001209191-22-034175.txt : 20220603 0001209191-22-034175.hdr.sgml : 20220603 20220603170036 ACCESSION NUMBER: 0001209191-22-034175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Donnell Niall CENTRAL INDEX KEY: 0001780235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40315 FILM NUMBER: 22995534 MAIL ADDRESS: STREET 1: C/O RIVERVEST VENTURE PARTNERS STREET 2: 101 SOUTH HANLEY RD., STE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18575 JAMBOREE ROAD STREET 2: SUITE 275-S CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (858) 283-0280 MAIL ADDRESS: STREET 1: 18575 JAMBOREE ROAD STREET 2: SUITE 275-S CITY: IRVINE STATE: CA ZIP: 92612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-01 0 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001780235 O'Donnell Niall C/O RENEO PHARMACEUTICALS, INC. 18575 JAMBOREE ROAD, SUITE 275-S IRVINE CA 92612 1 0 0 0 Stock Option (right to buy) 2.09 2022-06-01 4 A 0 17500 0.00 A 2032-05-31 Common Stock 17500 17500 D The shares subject to the option vest on the earlier of June 1, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. /s/ Gregory J. Flesher, Attorney-in-Fact 2022-06-03